Both in Pharmaceuticals
Abbott Laboratories vs Johnson & Johnson
Over the past year ABT returned −14.1% and JNJ returned +44.6%; their daily moves had a correlation of 0.28.
ABT −14.1% JNJ +44.6%Growth of $1, one year, split-adjusted
| Metric | ABT | JNJ |
|---|---|---|
| Price | $106.20 | $273.20 |
| Market cap | $183.77B | $657.68B |
| Today | +1.56% | −0.73% |
| 1 month | +9.8% | +5.6% |
| 6 months | +18.7% | +20.3% |
| Year to date | −15.2% | +32.0% |
| 1 year | −14.7% | +46.4% |
| Revenue growth (YoY) | +13.0% | +5.9% |
| Gross margin | 57.7% | 68.1% |
| Net margin | 7.4% | 0.8% |
| P/E (TTM) | 33.9× | 40.9× |
| Price / sales | 3.9× | 6.6× |
| Net cash | -$27.00B | -$27.42B |
| Dividend yield | 2.37% | 1.96% |
| Volatility (60d) | 21.3% | 23.4% |
| Short % of float | 1.0% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).